Curiox Biosystems Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	20,230	24,188	17,909	5,597	11,003	7,043
Short-Term Investments	2,000	4,000	-	3,125	8,816	809.54
Cash & Short-Term Investments	22,230	28,188	17,909	8,722	19,819	7,853
Cash Growth	69.92%	57.39%	105.34%	-55.99%	152.38%	-
Accounts Receivable	986.71	557.32	1,723	1,832	1,240	1,146
Other Receivables	108.11	132.13	98.19	68.97	86.29	86.63
Receivables	1,095	689.45	1,821	1,901	1,326	1,232
Inventory	1,225	1,791	1,621	2,911	1,759	595.7
Prepaid Expenses	263.13	356.57	173.81	79.92	23.37	12.77
Other Current Assets	4,220	1,242	75.54	336.57	132.05	197.54
Total Current Assets	29,033	32,267	21,601	13,949	23,060	9,891
Property, Plant & Equipment	1,405	2,095	2,391	998.06	543.1	427.33
Long-Term Investments	-	-	-	-	0	-0
Goodwill	25,631	26,059	23,547	22,733	21,143	19,819
Other Intangible Assets	9,167	9,922	10,056	10,761	10,969	11,196
Other Long-Term Assets	192.05	217.71	203.37	185.77	78.5	32.68
Total Assets	65,428	70,561	57,798	48,627	55,793	41,367
Accounts Payable	148.4	190.32	330	929.48	937.19	127.39
Accrued Expenses	382.19	595.99	375.03	537.34	441.11	201
Short-Term Debt	8,242	7,398	-	-	30,148	11,857
Current Portion of Leases	306.6	423.79	358.97	219.12	56.96	25.65
Current Unearned Revenue	832.03	585.74	669.72	539.41	286.02	107.22
Other Current Liabilities	26,531	10,723	982.85	609.44	411.63	353.16
Total Current Liabilities	36,442	19,918	2,717	2,835	32,281	12,672
Long-Term Debt	-	-	-	-	-	126.73
Long-Term Leases	180.77	319.98	606.19	168.09	241.58	157.86
Long-Term Deferred Tax Liabilities	1,557	1,685	1,592	1,764	1,564	1,734
Other Long-Term Liabilities	-	0	-	0	0	-0
Total Liabilities	38,180	21,923	4,915	4,767	34,087	14,690
Common Stock	8,081	8,062	4,011	3,284	543	543
Additional Paid-In Capital	85,665	85,431	88,965	71,651	27,944	27,944
Retained Earnings	-75,435	-53,556	-45,466	-35,426	-23,931	-9,407
Comprehensive Income & Other	8,931	8,695	5,369	4,344	1,027	-1,805
Total Common Equity	27,243	48,632	52,879	43,853	5,582	17,274
Minority Interest	4.59	5.06	4.93	7.82	10.82	10.13
Shareholders' Equity	27,247	48,637	52,883	43,861	21,707	26,677
Total Liabilities & Equity	65,428	70,561	57,798	48,627	55,793	41,367
Total Debt	8,729	8,142	965.16	387.21	30,446	12,168
Net Cash (Debt)	13,501	20,045	16,944	8,334	-10,627	-4,315
Net Cash Growth	10.18%	18.30%	103.30%	-	-	-
Net Cash Per Share	837.73	1216.70	1185.37	1174.42	-815.46	-331.09
Filing Date Shares Outstanding	16.16	16.12	16.04	13.14	13.03	13.03
Total Common Shares Outstanding	16.16	16.12	16.04	13.14	13.03	13.03
Working Capital	-7,409	12,349	18,884	11,115	-9,221	-2,781
Book Value Per Share	1685.54	3016.12	3295.64	3337.89	428.32	1325.52
Tangible Book Value	-7,555	12,651	19,276	10,359	-26,530	-13,741
Tangible Book Value Per Share	-467.45	784.63	1201.37	788.46	-2035.79	-1054.44
Machinery	2,524	2,837	2,440	1,219	740.14	704.78
Construction In Progress	45.93	102.38	-	-	-	-

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.